The relationship between maternal smoking and the incidence of congenital anomalies

Insights

Maternal smoking during pregnancy did not significantly increase overall congenital anomalies. However, heavy smoking (≥20 cigarettes/day) was linked to increased risks, particularly in male offspring for moderate anomalies.

Area of Science:

  • Reproductive Health
  • Pediatrics
  • Epidemiology

Background:

  • Maternal smoking is a known risk factor for adverse pregnancy outcomes.
  • The specific impact of smoking dose on congenital anomalies requires further investigation.

Purpose of the Study:

  • To examine the association between maternal smoking during pregnancy and the incidence of congenital anomalies in offspring.
  • To investigate dose-response relationships and specific anomaly types.

Main Methods:

  • A longitudinal study of 14,735 children born to mothers enrolled in the Child Health and Development Studies.
  • Comparison of congenital anomaly incidence between non-smokers, past smokers, and current smokers (categorized by cigarette consumption).

Main Results:

  • No significant overall increase in congenital anomalies for smokers versus non-smokers.
  • Heavy smoking (≥20 cigarettes/day) was associated with a significant increase in congenital anomalies, predominantly moderate anomalies in male offspring.
  • Increased incidence of inguinal hernia and strabismus observed with maternal smoking.
  • Decreased incidence of moderate musculoskeletal anomalies in male offspring of smokers.

Conclusions:

  • Maternal smoking, particularly heavy smoking, is associated with an increased risk of specific congenital anomalies.
  • The relationship between smoking and congenital anomalies is complex, with varying effects based on smoking dose and anomaly type.
  • Further research is needed to elucidate the underlying causal mechanisms.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...